Skip to content
  • Home
  • About IPPI
    • Our Purpose
    • Team & Affiliates
    • Advisory Board
    • Funding & Support
    • Institutional Partners
    • History
  • Blog
    • IPPI Blog
    • List of All Blog Posts
  • Writing
    • Amicus Briefs
    • Letters, Comments, & Testimony
    • Policy Writing
    • Scholarship
  • Events
    • All Events
    • Conflicts Calendar
    • IPPI 2026 Winter Institute
      • 2026 Agenda
    • WIPO-U.S. Summer School on IP
      • 2026 Draft Agenda
  • Edison Fellowship
  • Contact
IPPI: The IP Policy Institute

IPPI: The IP Policy Institute

The University of Akron School of Law

[Archived Post] Policy Brief: The TRIPS Waiver for COVID-19 Vaccines, and Its Potential Expansion: Assessing the Impact on Global IP Protection and Public Health

Posted on: December 14, 2022May 13, 2026Patents , Pharma

This policy brief, including the following “Introduction and Executive Summary,” comes from Eric M. Solovy. CLICK HERE to read the brief in full. Introduction and Executive Summary On June 17, […]

[Archived Post] FTC Chair and Commissioners Weigh in on SEP Litigation at the ITC

Posted on: August 24, 2022May 13, 2026FTC , Patent Law , Patents

The following post comes from Jack Ring, a rising 2L at Scalia Law and a Research Assistant at C-IP2. I. INTRODUCTION In a previous blog post, we discussed the dispute […]

[Archived Post] Philips and Thales’ Standard Essential Patent Fight at the Federal Circuit, District Court, and ITC

Posted on: August 18, 2022May 13, 2026FTC , ITC , Patents

The following post comes from Jack Ring, a rising 2L at Scalia Law and a Research Assistant at C-IP2. Click here for a related post. I. INTRODUCTION On July 13, […]

[Archived Post] Reply and Response to C-IP2’s March 4, 2021, Blogpost on UC Hastings’ Evergreen Drug Patent Search Database

Posted on: September 14, 2021May 13, 2026Biotech , Patents , Pharma

C-IP2’s original post on the UC Hastings’ Evergreen Drug Patent Search Database can be read here. Reply to Blog Post on UC Hastings’ Evergreen Drug Patent Search Database Robin Feldman […]

[Archived Post] Panel Discussion: Vaccines, Intellectual Property, and Global Equity

Posted on: July 6, 2021May 13, 2026Biotech , C-IP2 News , International Law , Patents

The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at C-IP2.  The COVID-19 pandemic has shined a spotlight on the role of intellectual […]

[Archived Post] WTO IP Waiver Too Simplistic: Global Vaccine Tech-Transfer Needs Other Strategies

Posted on: April 29, 2021May 13, 2026Healthcare , Patents

By Yogesh Pai Since October 2020, India and South Africa, joined by two-thirds of the WTO Members (African Group, LDCs and most of developing world) have been actively pursuing other […]

[Archived Post] Professor Tabrez Ebrahim on Clean and Sustainable Technological Innovation

Posted on: March 25, 2021May 13, 2026Innovation , Patents

The following post comes from Associate Professor of Law Tabrez Ebrahim of California Western School of Law in San Diego, California. By Tabrez Ebrahim What role should patent law have […]

[Archived Post] Accenture Report Outlines How 5G Technology Accelerates Economic Growth

Posted on: March 8, 2021May 13, 2026High Tech Industry , Patents

The following post comes from Wade Cribbs, a 2L at Scalia Law and a Research Assistant at CPIP. By Wade Cribbs Everyone in the technology industry knows that 5G is […]

[Archived Post] UC Hastings’ Evergreen Drug Patent Search Database: A Look Behind the Statistics Reveals Problems with this Approach to Identifying and Quantifying So-Called “Evergreening”

Posted on: March 4, 2021May 13, 2026Patents , Pharma

Professor Robin Feldman’s reply to this post, and our response, can be read read here. The Center for Innovation, housed at the University of California Hastings College of the Law, has […]

[Archived Post] Jonathan Barnett on Competition Regulators and Standard-Essential Patents

Posted on: February 17, 2021May 13, 2026Antitrust , Patents

The following post comes from Connor Sherman, a 2L at Scalia Law and a Research Assistant at CPIP. By Connor Sherman The field of intellectual property (IP) can sometimes be […]

Posts pagination

Previous page Page 1 Page 2 Page 3 … Page 5 Next page

Recent Posts

  • Domestic Manufacturing as a Discretionary Consideration: Domestic Industry at the PTAB?
  • If AI Can Pirate the Internet, Why Can’t You?
  • Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs
  • IPPI 2026 Spring Progress Report
  • IPPI 2025 Winter Progress Report

Archives

Theme Alaska Blog by Kantipur Themes